DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • June 30th, 2014 • Loxo Oncology, Inc. • Pharmaceutical preparations • New York
This DRUG DISCOVERY COLLABORATION AGREEMENT (the “Agreement”), effective as of July 3, 2013 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), and Loxo Oncology, Inc., a Delaware corporation, having an address at c/o Aisling Capital, 888 7th Avenue, 30th Floor, New York, New York 10106 (“Loxo”).
SEVENTH AMENDMENT TO DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • May 7th, 2015 • Array Biopharma Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 7 (“Seventh Amendment”), effective as of the Settlement Effective Date (defined below) (“Amendment Date”), is entered into by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), (collectively, the “Parties” or individually, a “Party”).
DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • March 14th, 2008 • Intermune Inc • Pharmaceutical preparations • Colorado
This DRUG DISCOVERY COLLABORATION AGREEMENT (the “Agreement”), effective as of September 13, 2002 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), and InterMune, Inc., a Delaware corporation, having a principal place of business at 3280 Bayshore Boulevard, Brisbane, California 94005 (“InterMune”).
SIXTH AMENDMENT TO DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • November 9th, 2010 • Array Biopharma Inc • Pharmaceutical preparations
This Amendment No. 6 (“Sixth Amendment”), effective as of September 30, 2010 (“Amendment Date”), is entered into by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), (collectively, the “Parties” or individually, a “Party”).
BETWEENDrug Discovery Collaboration Agreement • September 15th, 2000 • Array Biopharma Inc • Washington
DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • February 4th, 2015 • Array Biopharma Inc • Pharmaceutical preparations
THIS AMENDMENT NO.3 TO DRUG DISCOVERY COLLABORATION AGREEMENT (this "Amendment") effective as of October 13, 2014 (the "Amendment Date"), is made by and between Array BioPharma Inc., a Delaware corporation ("Array"), and Loxo Oncology, Inc., a Delaware corporation ("Loxo").
AMENDMENT NO. 5 TO DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • March 15th, 2016 • Loxo Oncology, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO.5 TO DRUG DISCOVERY COLLABORATION AGREEMENT (“Amendment”), effective February 18, 2016 (the “Amendment Date”), is by and between Array BioPharma Inc., a Delaware corporation (“Array”), and Loxo Oncology, Inc., a Delaware corporation (“Loxo”).
AMENDMENT NO. 3 TO DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • March 27th, 2015 • Loxo Oncology, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO.3 TO DRUG DISCOVERY COLLABORATION AGREEMENT (this “Amendment”) effective as of October 13, 2014 (the “Amendment Date”), is made by and between Array BioPharma Inc., a Delaware corporation (“Array”), and Loxo Oncology, Inc., a Delaware corporation (“Loxo”).
AMENDMENT NO. 4 TO DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • May 14th, 2015 • Loxo Oncology, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 4 TO DRUG DISCOVERY COLLABORATION AGREEMENT (this “Amendment”) effective as of March 31, 2015 (the “Amendment Date”), is made by and between Array BioPharma Inc., a Delaware corporation (“Array”), and Loxo Oncology, Inc., a Delaware corporation (“Loxo”).
DRUG DISCOVERY COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND ARRAY BIOPHARMA INC.Drug Discovery Collaboration Agreement • February 2nd, 2004 • Array Biopharma Inc • Services-medical laboratories • New York
This Drug Discovery Collaboration Agreement (“Agreement”) is made and entered into, effective as of December 22, 2003 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), (collectively, the “Parties” or individually, a “Party”).
AMENDMENT NO. 1 TO DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • August 15th, 2014 • Array Biopharma Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 TO DRUG DISCOVERY COLLABORATION AGREEMENT (this “Amendment”) effective as of November 26, 2013 (the “Amendment Date”), is made by and between Array BioPharma Inc., a Delaware corporation (“Array”), and Loxo Oncology, Inc., a Delaware corporation (“Loxo”).
DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • August 21st, 2015 • Array Biopharma Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 4 TO DRUG DISCOVERY COLLABORATION AGREEMENT (this “Amendment”) effective as of March 31, 2015 (the “Amendment Date”), is made by and between Array BioPharma Inc., a Delaware corporation (“Array”), and Loxo Oncology, Inc., a Delaware corporation (“Loxo”).
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. DRUG DISCOVERY COLLABORATION AGREEMENT BETWEEN GENENTECH, INC. AND CURIS, INC.Drug Discovery Collaboration Agreement • April 29th, 2005 • Curis Inc • Biological products, (no disgnostic substances) • California
THIS DRUG DISCOVERY COLLABORATION AGREEMENT (“Agreement”) is made and entered into, effective as of April 1, 2005 (“Effective Date”), by and between Genentech, Inc., a Delaware corporation, having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”) and Curis Inc., a Delaware corporation, having a principal place of business at 61 Moulton Street, Cambridge, Massachusetts 02138 (“Curis”), (collectively, the “Parties” or individually, a “Party”).
AMENDMENT NO. 2 TO DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • August 15th, 2014 • Array Biopharma Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 2 TO DRUG DISCOVERY COLLABORATION AGREEMENT (this “Amendment”) effective as of April 10, 2014 (the “Amendment Date”), is made by and between Array BioPharma Inc., a Delaware corporation (“Array”), and Loxo Oncology, Inc., a Delaware corporation (“Loxo”).
DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • November 14th, 2017 • Colorado
This DRUG DISCOVERY COLLABORATION AGREEMENT (the “Agreement”), effective as of September 13, 2002 (the “Effective Date”), is made by and between AAAA Inc., a ________ corporation, having a principal place of business at ________ (“AAAA”), and IIII, Inc., a ________ corporation, having a principal place of business at ________ (“IIII”).
DRUG DISCOVERY COLLABORATION AGREEMENTDrug Discovery Collaboration Agreement • September 13th, 2005 • Array Biopharma Inc • Services-medical laboratories • Colorado
This DRUG DISCOVERY COLLABORATION AGREEMENT (the “Agreement”), effective as of September 13, 2002 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), and InterMune, Inc., a Delaware corporation, having a principal place of business at 3280 Bayshore Boulevard, Brisbane, California 94005 (“InterMune”).
